Arrowhead Pharmaceuticals could notch more gains as the biotechnology firm prepares to release data tied to clinical trials ...

With a few chemical tweaks and some dutiful protein partners, a new biotech from Flagship Pioneering thinks it has cracked ...

Stuart Milstein appointed Chief Platform Officer, bringing decades of experience in oligonucleotide drug development to underpin Aerska’s platform R&DLisa Taylor Ash joins Board of Directors, ...

Nanomedicine prompts RNA to make protein-based drugs to treat diseases. Now we can fine-tune protein production by dialling ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on May 7, 2026, at 4:30 p.m. ET to discuss its financial results for the fiscal 2026 ...

Getting hands-on research experience from mentors at MUSC’s Hollings Cancer Center is allowing 10 College of Charleston ...

A newly discovered RNA-based mechanism helps CRISPR systems maintain efficiency by preventing interference, offering insights ...

Featured In Biomedwire Editorial Highlighting Biotech's Shift Toward Science-Driven Asset Valuation. Oncotelic Therapeutics (OTCQB: OTLC) is featured in recent BioMedWire editorial coverage ...

If CRISPR stays active too long, it could cut unintended parts of the genome. To reduce this risk, the researchers designed a self-inactivating CRISPR system. This means that CRISPR edits the gene and ...

A Martin-Gatton College of Agriculture, Food and Environment researcher is leading a new project that could help farmers ...

Graph theory and computational modeling reveal that neural network architecture biases the male Caenorhabditis elegans brain toward prioritized sexual behaviors.